Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Comparative Analysis of Splanchnic Vein Thrombosis Prevalence and Clinical Relevance Versus Other Thromboses in Hispanic Patients with Myeloproliferative Neoplasms

Jessica Zalapa, Elena Juventina Tuna Aguilar, Laura Ceja Ramirez, Juan Rangel-Patiño, Angel Gabriel Vargas Ruiz, Martin Pacheco Serrano

Blood (2024) 144 (Supplement 1): 6646.

https://doi.org/10.1182/blood-2024-208023

Published: 2024

Journal Articles

Shallow Whole Genome Sequencing of Circulating Tumor DNA Is Predictive of Outcome in Diffuse Large B-Cell Lymphoma

Davidson Zhao, Victoria Shelton, Inna Gong, Juan Rangel-Patiño, Ting Liu, Michael Hong, Vanessa Murad, Ur Metser, Anca Prica, Vishal Kukreti, Sita Bhella, Abi Vijenthira, Michael Crump, John Kuruvilla, Bernard Lam, Robert Kridel

Blood (2024) 144 (Supplement 1): 1606.

https://doi.org/10.1182/blood-2024-199677

Published: 2024

Journal Articles

Rate of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated with First-Line Bendamustine Rituximab and Rituximab Maintenance

Juan Rangel-Patiño, John Kuruvilla, Anca Prica, Robert Kridel, Sita D. Bhella, Vishal Kukreti, Jan Delabie, Abi Vijenthira, Manjula Maganti, Michael Crump

Blood (2024) 144 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2024-210922

Published: 2024

Journal Articles

Liver Steatosis and Metabolic Toxicities in Acute Lymphoblastic Leukemia Adults Undergoing Asparaginase-Based Therapy: Findings from a Non-Invasive Assessment Study

Fausto A Rios-Olais, Alicia K Pérez-Rojas, Ivan Arnaud-Borboa, Analy Mora, Guillermo Rosales-Sotomayor, Jonahi S Serrano-Heredia, Juan Luis Ontiveros-Austria, Juan Rangel-Patiño, Roberta Demichelis

Blood (2024) 144 (Supplement 1): 1420.

https://doi.org/10.1182/blood-2024-194026

Published: 2024

Journal Articles

Is Hepatic Toxicity during Induction Chemotherapy a Real Problem in Hispanic Young Adults with Acute Lymphoblastic Leukemia?

Jessica Zalapa, Mario Meza, Juan Rangel-Patiño, Roberta Demichelis

Blood (2022) 140 (Supplement 1): 8904–8905.

https://doi.org/10.1182/blood-2022-170699

Published: 2022

Journal Articles

Long-Term Outcomes in Patients with Idiopathic Portal Venous System Thrombosis (PVST) in a Limited Resource Setting. Should We Do an Extensive Thrombophilia Work-up?

Fernando Gil López, Fausto Rios Olais, Angel Gabriel Vargas Ruiz, Roberta Demichelis, Frida Ayala Aguillón, Analy Mora Cañas, Jorge Luis Alcazar Ylizaliturri, Juan Rangel-Patiño

Blood (2022) 140 (Supplement 1): 7866–7867.

https://doi.org/10.1182/blood-2022-168302

Published: 2022

Journal Articles

Effectiveness and Security of a Modified CALGB10403 in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in Low-and-Middle-Income Countries: A Multicentric Experience in Central America

Juan Rangel-Patiño, Lee-Tsai Yu Ling, Victor Itaí Urbalejo Ceniceros, Maria Elena Monserrat Luna Perez, Karla Adriana Espinosa, Lauro Fabian Amador, Alvaro Cabrero Garcia, Carolina Balderas-Delgado, Sergio I Inclan-Alarcon, Yvette Neme Yunes, Luis Meillon-García, Jose Manuel Sanchez Albarran, Elia Ixel Apodaca, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 2284.

https://doi.org/10.1182/blood-2021-153545

Published: 2021

Journal Articles

Low Bone Mass and Osteoporosis in Hispanic Acute Lymphoblastic Leukemia Survivors. Is It a Real Problem ?

Alfonso Orozco, Juan Rangel-Patiño, Mayra Valdez-Carrizales, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 5015.

https://doi.org/10.1182/blood-2021-151526

Published: 2021

Journal Articles

Improvement Diagnosis and Treatment of Mantle Cell Lymphoma in a Middle-Income Country: A Time-Dependent Analysis in Mexico

Juan Rangel-Patiño, Perla R. R. Colunga-Pedraza, Gladys P Agreda, Oyuky Gissell Aguirre-Reyes, David Gomez-Almaguer, Ana Florencia Ramirez-Ibarguen

Blood (2021) 138 (Supplement 1): 3051.

https://doi.org/10.1182/blood-2021-149988

Published: 2021

Journal Articles

Over-Expression of CRLF2 By Flow Cytometry (FC) Impacts on Overall Survival (OS) in Mexican Patients with Acute Lymphoblastic Leukemia (ALL)

Emmanuel Almanza Huante, Juan Rangel-Patiño, Rosana Daniela Córdova-Serrano, Karla Adriana Espinosa, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 3367.

https://doi.org/10.1182/blood-2021-153309

Published: 2021

Journal Articles

Are Delays in the Diagnosis and Treatment of Acute Leukemia in a Middle-Income Country Associated with Poor Outcomes?

Yadith Karina López García, Mayra Valdez-Carrizales, Jorge Adrian Nuñez-Zuno, Elia Ixel Apodaca, Juan Rangel-Patiño, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 5008.

https://doi.org/10.1182/blood-2021-148056

Published: 2021

Journal Articles

Total Oral Anticoagulation for Classic PNH As Primary Prophylaxis Strategy in a Complement Inhibitor Restricted Scenario: A Retrospective Analysis

Elia Apodaca Chavez, Juan Rangel-Patiño, Elena Juventina Tuna-Aguilar, Aurea Garcés-Martínez, Roberta Demichelis

Blood (2021) 138 (Supplement 1): 1118.

https://doi.org/10.1182/blood-2021-153515

Published: 2021

Journal Articles

Search for and Extraction of Accessory Spleen in Refractory Immune Cytopenias. Effective or a Waste in Resources?

José Miguel Alvarez Blanco, MD, Ana Sierra Salazar, MD, Juan Rangel-Patiño, MD, Roberta Demichelis, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-140454

Published: 2020

Journal Articles

Low Prevalence of T-Cell Lymphoblastic Leukemia/Lymphoma in an Adult Hispanic Population: A Report of the Acute Leukemia Working Group (GTLA)

Luis Felipe Rubalcava-Lara, MD, Emmanuel Almanza Huante, MDMD, Roberta Demichelis, MD, Juan Rangel-Patiño, MD, Andres Gomez-De Leon, MD, Gerardo A De la rosa-Flores, MD, Alvaro Cabrera Garcia, katheryn Betsabe Garzon, MD, Karla Adriana Espinosa, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-142639

Published: 2020

Journal Articles

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139018

Published: 2020

Journal Articles

Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?

Félix Gibrant Marquez, MD, Santiago Riviello-Goya, MD, Angel Gabriel Vargas Ruiz, Edgar Ortíz Brizuela, MD, Fernando Gil López, MD, Alfredo Gutierrez Marín, MD, María Fernanda Gonzalez Lara, MD, Alfredo Ponce de Léon Garduño, MD, José Sifuentes Osornio, PhD, Juan Rangel-Patiño, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-136240

Published: 2020

Journal Articles

Pediatric-Inspired Regimens Are Associated with Better Outcomes When Compared with Hypercvad in Hispanic Adolescents and Young Adults with Acute Lymphoblastic Leukemia

Roberta Demichelis, MD, Karla Adriana Espinosa, MD MSc, Juan Rangel-Patiño, MD, Emmanuel Almanza, MD, Ana Cooke, MD

Blood (2019) 134 (Supplement_1): 3877.

https://doi.org/10.1182/blood-2019-125370

Published: 2019

Journal Articles

A Modified CALGB-10403 in Hispanic Adolescent and Young Adults with Philadelphia -Negative Acute Lymphoblastic Leukemia: Promising Results Despite a High-Rate of Metabolic and Hepatic Toxicities

Juan Rangel-Patiño, MD, Alvaro Cabrero Garcia, Carolina Balderas-Delgado, MD, Lauro Fabian Amador, MD, Yvette Neme Yunes, Ana Cooke, MD, Adriana Rosas, Roberta Demichelis, MD

Blood (2019) 134 (Supplement_1): 1352.

https://doi.org/10.1182/blood-2019-126108

Published: 2019

Journal Articles

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Cesar Vargas-Serafin, MD, Aldo A Acosta-Medina, MS, Juan Rangel-Patiño, MD, Daniela Perez-Samano, MD, Deborah M. Martinez-Banos, Christianne Bourlon, MD

Blood (2019) 134 (Supplement_1): 5527.

https://doi.org/10.1182/blood-2019-128791

Published: 2019

NARROW

Comparative Analysis of Splanchnic Vein Thrombosis Prevalence and Clinical Relevance Versus Other Thromboses in Hispanic Patients with Myeloproliferative Neoplasms

Shallow Whole Genome Sequencing of Circulating Tumor DNA Is Predictive of Outcome in Diffuse Large B-Cell Lymphoma

Rate of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated with First-Line Bendamustine Rituximab and Rituximab Maintenance

Liver Steatosis and Metabolic Toxicities in Acute Lymphoblastic Leukemia Adults Undergoing Asparaginase-Based Therapy: Findings from a Non-Invasive Assessment Study

Is Hepatic Toxicity during Induction Chemotherapy a Real Problem in Hispanic Young Adults with Acute Lymphoblastic Leukemia?

Long-Term Outcomes in Patients with Idiopathic Portal Venous System Thrombosis (PVST) in a Limited Resource Setting. Should We Do an Extensive Thrombophilia Work-up?

Effectiveness and Security of a Modified CALGB10403 in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in Low-and-Middle-Income Countries: A Multicentric Experience in Central America

Low Bone Mass and Osteoporosis in Hispanic Acute Lymphoblastic Leukemia Survivors. Is It a Real Problem ?

Improvement Diagnosis and Treatment of Mantle Cell Lymphoma in a Middle-Income Country: A Time-Dependent Analysis in Mexico

Over-Expression of CRLF2 By Flow Cytometry (FC) Impacts on Overall Survival (OS) in Mexican Patients with Acute Lymphoblastic Leukemia (ALL)

Are Delays in the Diagnosis and Treatment of Acute Leukemia in a Middle-Income Country Associated with Poor Outcomes?

Total Oral Anticoagulation for Classic PNH As Primary Prophylaxis Strategy in a Complement Inhibitor Restricted Scenario: A Retrospective Analysis

Search for and Extraction of Accessory Spleen in Refractory Immune Cytopenias. Effective or a Waste in Resources?

Low Prevalence of T-Cell Lymphoblastic Leukemia/Lymphoma in an Adult Hispanic Population: A Report of the Acute Leukemia Working Group (GTLA)

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?

Pediatric-Inspired Regimens Are Associated with Better Outcomes When Compared with Hypercvad in Hispanic Adolescents and Young Adults with Acute Lymphoblastic Leukemia

A Modified CALGB-10403 in Hispanic Adolescent and Young Adults with Philadelphia -Negative Acute Lymphoblastic Leukemia: Promising Results Despite a High-Rate of Metabolic and Hepatic Toxicities

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only